• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,502.12 579.48
( 0.75%)
Global Indices
Nasdaq
52,333.78 -6.42
(-0.01%)
Dow Jones
7,505.37 -14.99
(-0.20%)
Hang Seng
68,854.54 -1,620.42
(-2.30%)
Nikkei 225
10,484.10 -13.02
(-0.12%)
Forex
USD-INR
94.60 0.11
(0.12%)
EUR-INR
107.91 0.13
(0.12%)
GBP-INR
125.27 0.26
(0.21%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
489.430006
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
46.57
1546.56
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0.02
 

Madhav Marbles and Granites consolidated net profit rises 7350.00% in the March 2026 quarter
Jun 01,2026
Net profit of Madhav Marbles and Granites rose 7350.00% to Rs 1.49 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025. Sales rose 20.47% to Rs 9.24 crore in the quarter ended March 2026 as against Rs 7.67 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.39 crore in the year ended March 2026 as against net loss of Rs 0.68 crore during the previous year ended March 2025. Sales declined 1.13% to Rs 30.71 crore in the year ended March 2026 as against Rs 31.06 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales9.247.67 20 30.7131.06 -1
OPM %-12.99-11.08 --7.07-0.32 -
PBDT3.200.10 3100 3.621.42 155
PBT2.48-0.72 LP 0.73-1.15 LP
NP1.490.02 7350 0.39-0.68 LP